Aperio Group’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $34.6M | Buy |
69,251
+8,686
| +14% | +$3.89M | 0.1% | 195 |
|
|
2020
Q3 | $23.8M | Buy |
60,565
+2,827
| +5% | +$1.05M | 0.08% | 239 |
|
|
2020
Q2 | $19.1M | Buy |
57,738
+660
| +1% | +$191K | 0.07% | 268 |
|
|
2020
Q1 | $13.8M | Sell |
57,078
-1,307
| -2% | -$341K | 0.06% | 310 |
|
|
2019
Q4 | $15.2M | Buy |
58,385
+921
| +2% | +$243K | 0.05% | 374 |
|
|
2019
Q3 | $15.6M | Buy |
57,464
+1,609
| +3% | +$448K | 0.06% | 344 |
|
|
2019
Q2 | $15.4M | Buy |
55,855
+1,836
| +3% | +$452K | 0.06% | 340 |
|
|
2019
Q1 | $12.1M | Buy |
54,019
+4,729
| +10% | +$976K | 0.05% | 393 |
|
|
2018
Q4 | $9.17M | Buy |
49,290
+992
| +2% | +$203K | 0.05% | 431 |
|
|
2018
Q3 | $12.1M | Buy |
48,298
+2,850
| +6% | +$692K | 0.05% | 385 |
|
|
2018
Q2 | $9.9M | Buy |
45,448
+2,327
| +5% | +$479K | 0.05% | 440 |
|
|
2018
Q1 | $8.25M | Sell |
43,121
-4
| -0% | -$738 | 0.04% | 492 |
|
|
2017
Q4 | $6.74M | Sell |
43,125
-1,264
| -3% | -$199K | 0.03% | 540 |
|
|
2017
Q3 | $6.9M | Sell |
44,389
-1,866
| -4% | -$295K | 0.04% | 499 |
|
|
2017
Q2 | $7.47M | Buy |
46,255
+7,573
| +20% | +$1.23M | 0.05% | 457 |
|
|
2017
Q1 | $5.98M | Buy |
38,682
+9,433
| +32% | +$1.3M | 0.04% | 487 |
|
|
2016
Q4 | $3.43M | Buy |
29,249
+5,176
| +22% | +$591K | 0.03% | 636 |
|
|
2016
Q3 | $2.71M | Buy |
24,073
+1,741
| +8% | +$183K | 0.02% | 735 |
|
|
2016
Q2 | $2.07M | Buy |
22,332
+2,594
| +13% | +$223K | 0.02% | 790 |
|
|
2016
Q1 | $1.55M | Buy |
19,738
+2,265
| +13% | +$163K | 0.01% | 872 |
|
|
2015
Q4 | $1.27M | Sell |
17,473
-48
| -0.3% | -$3.42K | 0.01% | 912 |
|
|
2015
Q3 | $1.3M | Buy |
17,521
+1,461
| +9% | +$105K | 0.01% | 878 |
|
|
2015
Q2 | $1.03M | Sell |
16,060
-480
| -3% | -$33.2K | 0.01% | 952 |
|
|
2015
Q1 | $1.28M | Buy |
16,540
+144
| +0.9% | +$11.2K | 0.01% | 851 |
|
|
2014
Q4 | $1.22M | Buy |
16,396
+552
| +3% | +$38.7K | 0.02% | 814 |
|
|
2014
Q3 | $933K | Sell |
15,844
-152
| -1% | -$9.61K | 0.01% | 888 |
|
|
2014
Q2 | $1.07M | Buy |
15,996
+718
| +5% | +$45.7K | 0.02% | 825 |
|
|
2014
Q1 | $927K | Buy |
+15,278
| New | +$910K | 0.01% | 1039 |
|
|
2013
Q4 | – | Sell |
-14,784
| Closed | -$778K | – | 1040 |
|
|
2013
Q3 | $737K | Buy |
14,784
+196
| +1% | +$9.42K | 0.01% | 974 |
|
|
2013
Q2 | $654K | Buy |
+14,588
| New | +$637K | 0.02% | 925 |
|
Other funds holding IDXX
Aperio Group's IDXX Position: Q4 2020 in Review
Aperio Group increased its Idexx Laboratories (IDXX) stake by 14% in Q4 2020, buying an estimated $3.89M and bringing the position to 69,251 shares worth $34.6M. The position accounts for 0.1% of the portfolio, ranked #195.
Aperio Group first reported a position in IDXX in Q2 2013 and has held it in 30 quarters since. 972 funds tracked by Wall St. Rank hold IDXX as of Q4 2020.
- Aperio Group held 69,251 shares of Idexx Laboratories worth $34.6M as of Q4 2020.
- Aperio Group bought 8,686 Idexx Laboratories shares in Q4 2020, an estimated $3.89M.
- Idexx Laboratories made up 0.1% of Aperio Group's portfolio in Q4 2020, its #195 holding.
- Aperio Group first reported a position in Idexx Laboratories in Q2 2013 and has held it in 30 quarters since.
- 972 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.